Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase®).
Dernoncourt A, Liabeuf S, Bennis Y, Masmoudi K, Bodeau S, Laville S, Hurtel-Lemaire AS, Gras-Champel V, Batteux B. Dernoncourt A, et al. Among authors: liabeuf s. BioDrugs. 2023 Jan;37(1):73-87. doi: 10.1007/s40259-022-00564-4. Epub 2022 Nov 19. BioDrugs. 2023. PMID: 36401769 Free PMC article.
Effectiveness and Tolerance of Renin-Angiotensin System Inhibitors With Aging in Chronic Kidney Disease.
Villain C, Metzger M, Liabeuf S, Hamroun A, Laville S, Mansencal N, Combe C, Fouque D, Frimat L, Jacquelinet C, Laville M, Ayav C, Briançon S, Pecoits-Filho R, Hannedouche T, Stengel B, Massy ZA; CKD-REIN Study Group. Villain C, et al. Among authors: liabeuf s. J Am Med Dir Assoc. 2022 Jun;23(6):998-1004.e7. doi: 10.1016/j.jamda.2021.10.019. Epub 2021 Nov 29. J Am Med Dir Assoc. 2022. PMID: 34856172
Polypharmacy in Patients with Chronic Kidney Disease.
Oosting IJ, Colombijn JMT, Kaasenbrood L, Liabeuf S, Laville SM, Hooft L, Bots ML, Verhaar MC, Vernooij RWM. Oosting IJ, et al. Among authors: liabeuf s. Kidney360. 2024 Apr 25. doi: 10.34067/KID.0000000000000447. Online ahead of print. Kidney360. 2024. PMID: 38661553 Free article.
Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review.
Barbieri M, Chiodini P, Di Gennaro P, Hafez G, Liabeuf S, Malyszko J, Mani LY, Mattace-Raso F, Pepin M, Perico N, Simeoni M, Zoccali C, Tortorella G, Capuano A, Remuzzi G, Capasso G, Paolisso G; CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target) collaborators. Barbieri M, et al. Among authors: liabeuf s. Pharmacol Res. 2024 May;203:107146. doi: 10.1016/j.phrs.2024.107146. Epub 2024 Mar 16. Pharmacol Res. 2024. PMID: 38493928 Free article. Review.
Medication-overuse headache: A pharmacovigilance study in France.
Al Balkhi MH, Moragny J, Laville SM, Liabeuf S, Pecquet PE, Batteux B, Le Souder C, Bellet F, Gras V, Masmoudi K. Al Balkhi MH, et al. Among authors: liabeuf s. Therapie. 2024 Feb 24:S0040-5957(24)00032-5. doi: 10.1016/j.therap.2024.02.001. Online ahead of print. Therapie. 2024. PMID: 38458945
The number of nephroprotection targets attained is associated with cardiorenal outcomes and mortality in patients with diabetic kidney disease. The CKD-REIN cohort study.
Bonnet F, Balkau B, Lambert O, Diawara Y, Combe C, Frimat L, Laville M, Liabeuf S, Massy ZA, Metzger M, Stengel B, Alencar de Pinho N, Fouque D. Bonnet F, et al. Among authors: liabeuf s. Diabetes Obes Metab. 2024 May;26(5):1908-1918. doi: 10.1111/dom.15507. Epub 2024 Feb 28. Diabetes Obes Metab. 2024. PMID: 38418407
Study of the association between serum levels of kynurenine and cardiovascular outcomes and overall mortality in chronic kidney disease.
El Chamieh C, Larabi IA, Alencar De Pinho N, Lambert O, Combe C, Fouque D, Frimat L, Jacquelinet C, Laville M, Laville S, Lange C, Alvarez JC, Massy ZA, Liabeuf S; Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Group. El Chamieh C, et al. Among authors: liabeuf s. Clin Kidney J. 2023 Sep 28;17(1):sfad248. doi: 10.1093/ckj/sfad248. eCollection 2024 Jan. Clin Kidney J. 2023. PMID: 38186868 Free PMC article.
Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients.
Hafez G, Malyszko J, Golenia A, Klimkowicz-Mrowiec A, Ferreira AC, Arıcı M, Bruchfeld A, Nitsch D, Massy ZA, Pépin M, Capasso G, Mani LY, Liabeuf S; CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target). Hafez G, et al. Among authors: liabeuf s. Clin Kidney J. 2023 Sep 18;16(12):2378-2392. doi: 10.1093/ckj/sfad239. eCollection 2023 Dec. Clin Kidney J. 2023. PMID: 38046029 Free PMC article. Review.
180 results